Atomo Diagnostics (ASX:AT1)
ASX announcement history & article coverage
Transparent by design.
Announcments by Atomo Diagnostics (ASX:AT1) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
2026 Notice of Annual General Meeting
FY26 Results and Strategy Presentation
Atomo FY26 Results and Strategy Presentation
2026 Appendix 4G and Corporate Governance Statement
FY26 Results Presentation
2026 Appendix 4E and Annual Report
Atomo Diagnostics reports 41% revenue growth, reduced loss, leadership change, and strategic expansion
Final Director's Interest Notice
Managing Director & CEO Transition
Atomo Diagnostics appoints Dr. Cheri Walker as interim CEO following John Kelly's departure
Quarterly Activities/Appendix 4C Cash Flow Report
Atomo Diagnostics reports 40% revenue growth and operational progress in Q4 FY26
Investor Webinar Presentation